Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
15.56
+0.18 (1.18%)
Dec 27, 2024, 9:37 AM EST - Market open
Assembly Biosciences Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for ASMB stock has a target of 35, which predicts an increase of 124.91% from the current stock price of 15.56.
Analyst Consensus: Buy
* Price targets were last updated on Sep 20, 2024.
Analyst Ratings
The average analyst rating for ASMB stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Dec 27, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 24, 2024 |
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $2 → $35 | Hold → Strong Buy | Upgrades | $2 → $35 | +124.91% | Sep 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jun 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jun 13, 2024 |
Financial Forecast
Revenue This Year
27.37M
from 7.16M
Increased by 282.16%
Revenue Next Year
22.54M
from 27.37M
Decreased by -17.66%
EPS This Year
-7.70
from -13.38
EPS Next Year
-7.80
from -7.70
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 32.9M | 35.7M | 110.3M | |||
| Avg | 27.4M | 22.5M | 46.7M | |||
| Low | 20.6M | n/a | 12.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 358.8% | 30.4% | 389.1% | |||
| Avg | 282.2% | -17.7% | 107.2% | |||
| Low | 187.3% | - | -45.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -7.21 | -7.62 | -8.94 | |||
| Avg | -7.70 | -7.80 | -9.32 | |||
| Low | -8.06 | -7.87 | -9.57 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.